ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.

Brenda F Kurland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.